The vast majority of TP53 mutations occur in exons 5–8 in conserved regions of the DNA binding domain and lead to a formation of a stable mutant protein that loses its tumor suppressive activities, such as the induction of cell cycle arrest, apoptosis, senescence, or DNA repair. This evidence concerns the gene TP53 and neoplasm.